关于患者报告的喘结果的最新情况
Tianshi David Wu1, Zuzana Diamant2, Nicola A Hanania3
1Section of Pulmonary, Critical Care, and Sleep Medicine, Baylor College of Medicine, Houston TX; Center for Innovations in Quality, Effectiveness, and Safety, Michael E. DeBakey VA Medical Center, Houston TX.
Chest
|February 16, 2024
概括
患者报告的结果测量 (PROM) 对于喘评估至关重要. 新的PROM可能会提高风险检测和药物开发,但它们的临床实用性需要进一步研究.
科学领域:
- 肺部医学 肺部医学
- 健康 结果 研究 研究 结果
- 临床试验方法论 临床试验方法论
背景情况:
- 患者报告的结果 (PROs) 提供了独特的健康见解,无法通过物理手段进行测量.
- 患者报告的结果指标 (PROMs) 标准化了PROs的评估.
- 在喘临床实践和研究中,PROM越来越重要.
研究的目的:
- 批判性地评估患者报告的喘结果措施 (PROMs).
- 提供关于PROM在喘管理和研究中的当前使用情况的最新信息.
- 为改善喘评估强调新型PROM.
主要方法:
- 对喘特异性PROMs现有文献的审查.
- 讨论新型PROMs的开发和应用.
- 对PROM在喘中的实用性和局限性的批判性评估.
主要成果:
- 喘特异性PROM评估症状,药物使用,恶化和功能障碍.
- 目前的指导方针包括用于控制喘的PROM,但现实世界的有效性数据有限.
- 新的PROM,如喘障碍和风险问卷和CompEx,显示出风险检测和临床试验的前景.
结论:
- PROMs是全面喘评估的重要工具.
- 新型PROM可以改善高风险患者的识别,并加速药物发现.
- 进一步的研究是必要的,以确定PROM在临床环境中的实际实用性.
相关概念视频
Asthma-IV: Nursing Management
3.1K
The nursing management of asthma is a comprehensive approach that relies heavily on the expertise and dedication of healthcare professionals. It involves thorough assessment, accurate diagnosis, strategic planning, effective implementation, and diligent evaluation. By meticulously following this step-by-step process, healthcare professionals play a crucial role in providing the best possible care and treatment for patients with asthma, enhancing their overall health and well-being.
First, in...
First, in...
3.1K
Asthma-III: Symptoms and Complications
2.5K
Asthma, a common chronic respiratory condition, is classified considering the frequency and severity of symptoms alongside lung function impairment. Understanding this classification is essential for appropriate treatment and management. Here's a detailed look at the classification of asthma and its clinical features and complications:
Classification of Asthma
Classification of Asthma
2.5K
Asthma-IV: Diagnostic and Management
2.5K
The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
2.5K
Asthma-I: Introduction
2.6K
Asthma is a chronic respiratory ailment that requires careful management due to its varying symptoms and influencing factors. It is characterized by airway inflammation, bronchial hyperresponsiveness, and reversible airflow obstruction, leading to symptoms like wheezing, shortness of breath, chest tightness, and coughing. The symptom frequency and intensity may vary considerably over time. It is also linked to immune system responses to allergens and irritants, highlighting the complex...
2.6K
Asthma-II: Pathophysiology and Classification
2.7K
Asthma is a prevalent chronic respiratory condition marked by inflammation and hyperresponsiveness of the airways. Its pathophysiology involves complex interactions among inflammatory pathways, immune responses, and neural mechanisms.
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
2.7K
Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
297
Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
297


